Slope of Hope Blog Posts

Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.

Exciting Times

By -

The market absolutely plunged on Monday morning, only to almost completely recover (or, in the case of the NQ, turn green!) by the end of the day. No surprise, right? You might assume I’d be pretty bummed. Nope! I actually love markets like this. I’m a swing trader, after all, and my desired holding period is weeks, not minutes. I don’t have a single option with fewer than 10 weeks left on it. So I’m not worried.

What I find exhilarating about this market is that it IS breaking down, and it keeps offering opportunities to get in at good prices. There are progressively walls of resistance being constructed, brick by brick. Tomorrow morning, for example, it’s entirely possible that Powell says things that the market doesn’t like, and we sell off hard, perhaps even taking out Monday’s lows. I don’t need that to happen, but it certainly could.

(more…)

New Fund=Time To Sell?

By -

A Sell Signal For An Asset Class?

In the video below, I note that Bitcoin has dropped by more than a third since the ProShares Bitcoin Strategy ETF (BITO) launched, and discuss a couple of other examples of similar phenomena that came to mind. The first was when Alliance Capital (as it was known at the time) launched its healthcare fund in the late ’90s. At the time, Pfizer (PFE) was one of its top holdings, and an archetypical one at that. It was selling two of the biggest drugs on the market: Warner-Lambert’s Lipitor (starting in 1996) and its own Viagra (starting in 1998). And yet Pfizer’s share price hit a high water mark a few years later that it didn’t regain until last year with its BioNTech (BNTX) COVID vaccine. 

(more…)